ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/23 | 1,718 | 1,741 | 1,702 | 1,735 | -6 | -0.3% | 1,009,600 |
| 2022/08/22 | 1,696 | 1,754 | 1,677 | 1,741 | +27 | +1.6% | 1,832,800 |
| 2022/08/19 | 1,667 | 1,728 | 1,662 | 1,714 | +54 | +3.3% | 1,536,000 |
| 2022/08/18 | 1,632 | 1,665 | 1,625 | 1,660 | +4 | +0.2% | 989,700 |
| 2022/08/17 | 1,624 | 1,674 | 1,619 | 1,656 | +19 | +1.2% | 1,094,000 |
| 2022/08/16 | 1,590 | 1,638 | 1,585 | 1,637 | +35 | +2.2% | 1,313,500 |
| 2022/08/15 | 1,606 | 1,622 | 1,581 | 1,602 | -18 | -1.1% | 1,078,100 |
| 2022/08/12 | 1,624 | 1,654 | 1,566 | 1,620 | +36 | +2.3% | 2,000,000 |
| 2022/08/10 | 1,621 | 1,625 | 1,572 | 1,584 | -75 | -4.5% | 1,438,300 |
| 2022/08/09 | 1,654 | 1,672 | 1,625 | 1,659 | +37 | +2.3% | 1,411,500 |
| 2022/08/08 | 1,593 | 1,641 | 1,588 | 1,622 | +9 | +0.6% | 1,192,000 |
| 2022/08/05 | 1,640 | 1,703 | 1,596 | 1,613 | +29 | +1.8% | 3,376,500 |
| 2022/08/04 | 1,568 | 1,611 | 1,543 | 1,584 | +14 | +0.9% | 2,252,500 |
| 2022/08/03 | 1,522 | 1,608 | 1,477 | 1,570 | +70 | +4.7% | 3,476,800 |
| 2022/08/02 | 1,560 | 1,637 | 1,485 | 1,500 | +70 | +4.9% | 7,170,600 |
| 2022/08/01 | 1,432 | 1,455 | 1,414 | 1,430 | ±0 | ±0% | 1,356,800 |
| 2022/07/29 | 1,370 | 1,488 | 1,362 | 1,430 | +106 | +8% | 4,073,000 |
| 2022/07/28 | 1,358 | 1,359 | 1,298 | 1,324 | -37 | -2.7% | 940,900 |
| 2022/07/27 | 1,327 | 1,369 | 1,327 | 1,361 | +33 | +2.5% | 858,500 |
| 2022/07/26 | 1,347 | 1,360 | 1,312 | 1,328 | -4 | -0.3% | 1,073,600 |
| 2022/07/25 | 1,331 | 1,340 | 1,304 | 1,332 | +27 | +2.1% | 1,078,800 |
| 2022/07/22 | 1,289 | 1,306 | 1,272 | 1,305 | +40 | +3.2% | 591,000 |
| 2022/07/21 | 1,260 | 1,299 | 1,254 | 1,265 | +7 | +0.6% | 971,700 |
| 2022/07/20 | 1,246 | 1,261 | 1,232 | 1,258 | +33 | +2.7% | 544,500 |
| 2022/07/19 | 1,233 | 1,236 | 1,205 | 1,225 | -19 | -1.5% | 813,500 |
| 2022/07/15 | 1,260 | 1,266 | 1,238 | 1,244 | -35 | -2.7% | 696,500 |
| 2022/07/14 | 1,238 | 1,289 | 1,223 | 1,279 | +61 | +5% | 1,031,900 |
| 2022/07/13 | 1,211 | 1,230 | 1,205 | 1,218 | +7 | +0.6% | 473,100 |
| 2022/07/12 | 1,170 | 1,212 | 1,170 | 1,211 | +31 | +2.6% | 633,100 |
| 2022/07/11 | 1,238 | 1,239 | 1,173 | 1,180 | -48 | -3.9% | 937,600 |
| 2022/07/08 | 1,235 | 1,254 | 1,213 | 1,228 | +5 | +0.4% | 635,300 |
| 2022/07/07 | 1,253 | 1,255 | 1,207 | 1,223 | -19 | -1.5% | 807,000 |
| 2022/07/06 | 1,183 | 1,255 | 1,183 | 1,242 | +77 | +6.6% | 1,401,300 |
| 2022/07/05 | 1,141 | 1,166 | 1,136 | 1,165 | +29 | +2.6% | 621,000 |
| 2022/07/04 | 1,138 | 1,149 | 1,122 | 1,136 | +16 | +1.4% | 403,000 |
| 2022/07/01 | 1,142 | 1,162 | 1,112 | 1,120 | -10 | -0.9% | 664,200 |
| 2022/06/30 | 1,140 | 1,152 | 1,122 | 1,130 | -7 | -0.6% | 520,600 |
| 2022/06/29 | 1,140 | 1,150 | 1,125 | 1,137 | -24 | -2.1% | 588,700 |
| 2022/06/28 | 1,121 | 1,166 | 1,121 | 1,161 | +35 | +3.1% | 1,047,500 |
| 2022/06/27 | 1,116 | 1,133 | 1,104 | 1,126 | +16 | +1.4% | 547,900 |
| 2022/06/24 | 1,100 | 1,116 | 1,087 | 1,110 | +35 | +3.3% | 898,100 |
| 2022/06/23 | 1,031 | 1,090 | 1,028 | 1,075 | +44 | +4.3% | 869,800 |
| 2022/06/22 | 1,040 | 1,044 | 1,018 | 1,031 | -2 | -0.2% | 389,100 |
| 2022/06/21 | 1,012 | 1,039 | 1,012 | 1,033 | +30 | +3% | 458,400 |
| 2022/06/20 | 1,026 | 1,035 | 991 | 1,003 | -16 | -1.6% | 729,300 |
| 2022/06/17 | 1,033 | 1,054 | 1,016 | 1,019 | -44 | -4.1% | 893,000 |
| 2022/06/16 | 1,101 | 1,106 | 1,062 | 1,063 | -16 | -1.5% | 589,300 |
| 2022/06/15 | 1,102 | 1,116 | 1,079 | 1,079 | -26 | -2.4% | 694,500 |
| 2022/06/14 | 1,162 | 1,162 | 1,090 | 1,105 | -77 | -6.5% | 1,280,500 |
| 2022/06/13 | 1,181 | 1,199 | 1,165 | 1,182 | -29 | -2.4% | 831,600 |
651～
700
件表示中 / 5073件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 237,600円 | +0.3% | +2.7% | 2.10% | 13.48倍 | 1.05倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| クオリプス | 805,000円 | +660.9% | - | 0.00% | - | 11.68倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
市場注目の銘柄
チャート関連のコラム
